ANAB Operating Cash Flow (Statement)
Anaptysbio Inc · Operating Cash Flow (Statement)
ANAB Operating Cash Flow (Statement)
Latest reported$18.08Mperiod ending
ANAB TTM Cash from Operations ($14.60M → $18.08M)
TTM operating cash flow (statement)
High-resolution chart · PNG
ANAB operating cash flow (statement) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| 18,082,000 | |
| 4,478,000 | |
| 19,697,000 | |
| -144,972,000 | |
| -127,706,000 | |
| -108,784,000 | |
| -135,337,000 | |
| -103,014,000 | |
| -129,398,000 | |
| -133,485,000 | |
| -120,800,000 | |
| -97,136,000 | |
| -78,409,000 | |
| -77,147,000 | |
| -73,593,000 | |
| -88,209,000 | |
| -77,468,000 | |
| -43,730,000 | |
| -45,920,000 | |
| 16,959,000 | |
| 6,952,000 | |
| -22,249,000 | |
| -14,157,000 | |
| -67,540,000 | |
| -72,623,000 | |
| -68,530,000 | |
| -69,517,000 | |
| -66,002,000 | |
| -58,766,000 | |
| -52,127,000 | |
| -48,506,000 | |
| -41,026,000 | |
| -30,054,000 | |
| -23,819,000 | |
| -19,438,000 | |
| -20,198,000 | |
| -19,383,000 | |
| -15,071,000 | |
| -9,030,000 | |
| -6,087,000 | |
| -4,845,000 | |
| -9,181,000 | |
| -9,669,000 | |
| -5,946,000 | |
| -4,022,000 | |
| -2,971,000 | |
| 14,603,000 |